Drug class in one race

IL-4R-alpha drugs for Asthma

2 tracked IL-4R-alpha drugs in the Asthma race. The class explanation lives on the IL-4R-alpha page; the full indication pipeline across every mechanism is on the Asthma page.

1 approved / phase 41 Phase 2

Head-to-head evidence: dupilumab vs Manfidokimab

The roster

← all IL-4R-alpha drugs